Article
Current and future alternative therapies for beta-thalassemia major
1 Feb 2016
Abstract excerpt
Beta-thalassemia is a group of frequent genetic disorders resulting in the synthesis of little or no β-globin chains. Novel approaches are being developed to correct the resulting α/β-globin chain imbalance, in an effort to move beyond the palliative management of this disease and the complications of its treatment (e.g. life-long red blood cell transfusion, iron chelation, splenectomy), which impose high costs...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
